Delivery Order SPE2DB24D2205-SPE2DB25FEHLJ
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $5,303.85 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4561466254 BIDIL 20 MG-37.5 MG tablets. The contract requires the delivery of 90 tablets to a location in Conshohocken, Pennsylvania by July 12, 2023, with performance starting on July 11, 2023. The Defense Logistics Agency Troop Support Medical supports the medical supply needs of the Department of...
- The Defense Logistics Agency awarded a $8,209.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561643741 BIDIL 20 MG-37.5 MG tablets. Amerisourcebergen Drug Corporation will provide 90 tablets of the specified medication to fulfill requirements under the order. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with work expected to conclude by July 31, 2023. As the prime contractor, Amerisourcebergen Drug...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,477.34, is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $6,286.72 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 90 tablets of BIDIL 20 MG-37.5 MG to be delivered to its Conshohocken, Pennsylvania facility by September 8, 2023. The contract was awarded utilizing the Medical-Surgical Federal Supply Schedule, a multiple award indefinite delivery/indefinite quantity contract vehicle managed by the Defense Logistics Agency Troop Support Medical to provide...
- The Defense Logistics Agency awarded a $4,865.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561463344 BIDIL 20 MG-37.5 MG tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 90 tablets to a location in Conshohocken, Pennsylvania by July 12, 2023 to fulfill requirements under the order. As the DLA supports procurement for the Department of Defense, this contract for pharmaceutical products is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,937.34 and is a firm fixed-price delivery order with a completion date of June 5, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,313.95 to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units). This firm fixed-price delivery order, awarded on July 18, 2025, was completed by July 21, 2025, with no set-aside designation applied. The award utilizes a competitive procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. Performance of this...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,001.33 on August 1, 2025, for the supply of Dalire 500 mcg tablets in a 30-count package. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHLJDelivery Order
The Defense Logistics Agency awarded a $8,973.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of BIDIL 20 mg-37.5 mg tablets (90 count). The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its substantial IDC with DLA to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The company's contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the vendor's established position as a critical supplier within the federal medical supply chain and its ability to meet competitive procurement standards for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/11/25 |